A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma

NCT05926492 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma

Interventions

DRUG: Surufatinib plus chemotherapy
DRUG: Chemotherapy

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University